0001566044-18-000013.txt : 20181212 0001566044-18-000013.hdr.sgml : 20181212 20181212184344 ACCESSION NUMBER: 0001566044-18-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181210 FILED AS OF DATE: 20181212 DATE AS OF CHANGE: 20181212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spellman Mary CENTRAL INDEX KEY: 0001740108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 181231826 MAIL ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Menlo Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-486-1416 MAIL ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-12-10 0 0001566044 Menlo Therapeutics Inc. MNLO 0001740108 Spellman Mary 200 CARDINAL WAY 2ND FLOOR REDWOOD CITY CA 94063 0 1 0 0 Chief Medical Officer Stock Option 5.51 2018-12-10 4 A 0 96000 0.0 A 2028-12-10 Common Stock 96000 96000 D The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly. By: /s/ Sunny Ryan, as attorney-in-fact For: Mary Spellman 2018-12-12